Chr. Hansen: probiotics can help minimise flu cost

2 Sep 2019

Chr. Hansen reports that a new health economics study shows that the intake of probiotics can help reduce the cost of flu-like sickness.

In the US alone, taking probiotics can reduce the number of sick days by over 54 million days per year, according to the study.

Chr. Hansen: probiotics can help minimise flu cost

Flu-like sickness can take its toll on workforce productivity, health care systems and families with young children, the company notes, and is estimated to have an annual burden on the US economy of $11.2 billion .

According to Chr. Hansen, data from numerous studies already shows a positive correlation between taking certain probiotics and reducing the number of incidents, duration and severity of flu-like sickness. This new study builds upon existing data, to assess the potential health economic impact of probiotics in the US primary care setting. The findings show the significant savings potential taking probiotics can have by reducing the number of sick days, visits to the doctor and prescriptions.

Flu-like sickness is a wide-ranging category including a fever of at least 100°F (37.8°C) and a cough or sore throat. On average over the last five years, there have been 33 million symptomatic cases in the US each year.

“Probiotics are already well established in the healthcare industry, and numerous studies have highlighted the therapeutic potential of specific probiotic strains in helping to maintain a healthy immune system and supporting the defense against harmful bacteria. In addition to the health benefits to an individual, this study demonstrates that taking probiotics also contributes to reducing costs to society and reducing the use of antibiotics. We believe that the impact of probiotics on healthcare will continue to grow in the years to come as we continue to unlock the potential of good bacteria,” said Andrew Scorey, senior vice president, Chr. Hansen Human Health.

Chr. Hansen points out that, according to the World Health Organization (WHO), antibiotic resistance is one of the biggest threats to global health, food security and development today, and it is expected to exceed cancer as the main cause of death by 2050. It is estimated that more than one in three of the antibiotics prescribed to treat flu-like sickness in the US are redundant.

The new study reveals that in the US, some 2.2 million antibiotic courses could be avoided each year if the population takes probiotics.

“We already know that the overuse of antibiotics can cause bacteria to become resistant, meaning current treatments will no longer work. This study provides further evidence of how probiotics and ‘good bacteria’ can respond to some of the world’s biggest challenges,” said Scorey.

The results of the study are published in the journal Frontiers in Pharmacology and were authored and reviewed by independent industry and academic experts. Chr. Hansen sponsored the development of a new simulation model used in the study. The publication title is: Probiotics reduce healthcare cost and societal impact of flu-like respiratory tract infections in the USA: An economic modeling study.

The underlying data used in the study came from two independent reviews: York Health Economics Consortium (YHEC) and Cochrane. The clinical trials in these reviews used 22 probiotic strains, including Chr. Hansen’s Lactobacillus rhamnosus and Bifidobacterium animalis.

“This study builds on independent clinical trials and translates the clinical findings into cost and impact on primary health care. The results present a very strong case for probiotics. At Chr. Hansen, we will continue to build on these findings looking closely into how specific strains can support this health area. As a result of this study, we now have a new simulation model that will provide us with new ways to work with data in future studies,” said Adam Baker, senior manager, Human Health Development at Chr. Hansen.

Chr. Hansen owns some of the world’s best documented probiotic strains. The large number of scientific publications and clinical studies on these strains indicate that they may have beneficial effects on the immune functions.

Related news

NZMP milk from Fonterra looks to help consumers manage stress

NZMP milk from Fonterra looks to help consumers manage stress

22 Apr 2021

Dairy producer Fonterra is looking to stem slumping milk sales by deconstructing the components of this dairy beverage and promoting its animal protein building blocks as an addition to applications catering to beauty-from-within and better-for-you tre...

Read more 
Danone Manifesto Ventures makes first UK-based investment

Danone Manifesto Ventures makes first UK-based investment

8 Apr 2021

Danone’s VC arm, Danone Manifesto Ventures (DMV) made its first investment in a UK-based business with its commitment to a £2.5m funding round for the healthy drinks brand Moju. Moju said the French Dairy giant’s minority investment in the company will...

Read more 
Ocean Spray launches Wave caffeinated sparkling water

Ocean Spray launches Wave caffeinated sparkling water

16 Mar 2021

Cranberry brand Ocean Spray launched a new line of functional water through an exclusive partnership with Walmart. Called Wave, the caffeinated sparkling water contains 50mg of caffeine derived from black tea, real fruit juice, and has no added sugars,...

Read more 
Healthy Height expands into China

Healthy Height expands into China

9 Mar 2021

Healthy Height, the nutritional shake brand which has been clinically proven to increase children’s height is expanding its e-commerce presence in China.

Read more 
Mood enhancing mineral salts

Mood enhancing mineral salts

17 Feb 2021

Magnesium, Zinc and Selenium Salts by Dr. Paul Lohmann® are natural mood enhancers.

Read more 
Hellowater partners with agricultural company on toxin-fighting beverage line

Hellowater partners with agricultural company on toxin-fighting beverage line

5 Feb 2021

Functional water brand Hellowater and the agriculture company Brandt are partnering to launch a line of beverages that employ Brandt’s toxin-elimination and immune-protection technology. In addition to co-producing a line of functional water, Brandt is...

Read more 
Cultivated fat is a potential popular addition to plant-based products

Cultivated fat is a potential popular addition to plant-based products

21 Jan 2021

Cultivated fat might be the next ingredient to melt the hearts of fans of plant-based products, with two-thirds of plant-based meat companies interested in incorporating the ingredient into their recipes, according to a survey Peace of Meat.

Read more 
Height-boosting protein drink launches in Asia

Height-boosting protein drink launches in Asia

27 Nov 2020

After successfully launching in the U.S., Israeli brand Nutritional Growth Solutions introduced its Healthy Height protein shake to the Asia-Pacific market. Alongside the product launch came a successful IPO on the Australian Stock Exchange where the c...

Read more 
Cham Foods releases pulse and grain-based instant meals

Cham Foods releases pulse and grain-based instant meals

24 Nov 2020

Israeli based Cham Foods has engineered a line of dry, ready-to-eat pulse- and grain-based instant meals. These new instant meals and soups contain legumes and grains that when hot water is added retain the shape and texture and take only minutes to ma...

Read more 
Beyond Meat unveils the next generation of its Beyond Burger

Beyond Meat unveils the next generation of its Beyond Burger

18 Nov 2020

Beyond Meat will release two new versions of its Beyond Burger: one with increased juiciness and the other with an improved nutritional profile. Both burgers will launch across the U.S. in 2021.

Read more